Researchers screened a library of drugs either FDA-approved or in clinical trial using a library of patient-derived H3K27M-mutant diffuse midline glioma cell lines with cell viability as the outcome.
[Neuro-Oncology]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
174042
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
